Semler Scientific Inc at Raymond James Human Health Innovation Conference (Virtual) Transcript
Good morning or afternoon on the East Coast at this point, and welcome to day 2 of the Raymond James Human Health Innovation Conference. Thanks for joining us. I am Andrew Cooper. I cover diagnostics here for Raymond James.
And I'm excited to be joined by Semler Scientific for a presentation this morning. It's a company that has bring some unique capabilities and frankly a unique channel approach to testing for peripheral artery disease, which is dramatically underdiagnosed in the US. But I will leave it to the team to offer more details there.
Before I do turn it over, we will have some time at the end for Q&A, so please feel free to submit any questions. (Conference Instructions) With that, like I said, we are happy to be joined by the Semler team: CEO, Doug Murphy-Chutorian; and Chief Marketing Officer, Dennis Rosenberg. And I will hand it over to you guys to begin the presentation. Thanks.
Hello. This is Dennis Rosenberg, Chief
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |